Cibus Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
CBUS Nasdaq 8731 https://calyxt.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cibus Inc

Jim Collins to Join Cibus Board of Directors - Sep 18th, 2023 9:23 pm
Cibus to Present at the H.C. Wainwright 25th Annual Global Investment Conference - Sep 5th, 2023 12:00 pm
Cibus Reports Second Quarter 2023 Financial Results and Provides Business Update - Aug 9th, 2023 9:00 pm
Steve Berreth Appointed as General Counsel and Corporate Secretary - Aug 3rd, 2023 4:30 pm
Cibus to Report Second Quarter 2023 Financial Results on August 10, 2023 and Host Conference Call - Aug 3rd, 2023 11:00 am
Cibus to Present at the Canaccord 43rd Annual Growth Conference - Aug 2nd, 2023 8:05 pm
Cibus Opens Dedicated, High-throughput Gene Editing Facility for Trait Production - Jul 12th, 2023 12:30 pm
Cibus Welcomes European Commission Proposal on Regulation of Plants Obtained from New Genomic Techniques - Jul 5th, 2023 8:05 pm
Cibus Applauds the Genetic Technology (Precision Breeding) Act 2023 Passed in the United Kingdom - Jun 15th, 2023 12:45 pm
Cibus to Participate in Upcoming Investor Conferences - Jun 15th, 2023 11:00 am
Cibus’ White Mold Resistance Trait in Canola Achieves Another Important Milestone - Jun 7th, 2023 11:00 am
Cibus Announces Closing of Merger with Calyxt to Create Industry Leading Precision Gene Editing and Trait Development Company - Jun 1st, 2023 11:00 am